Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Nelson, J. C. Articles by Roose, S. Search for Related Content PubMed Citation Articles by Nelson, J. C. Articles by Roose, S. Depression Syndromes Secondary to General Medical Disorders Antidepressants

Treatment of Major Depression With Nortriptyline and Paroxetine in Patients With Ischemic Heart Disease

OBJECTIVE: This study compared the efficacy, tolerability, and safety of paroxetine and nortriptyline in depressed patients with ischemic heart disease. METHOD: After a 2-week, single-blind placebo lead-in phase, 81 outpatients with DSM-III-R-defined nonpsychotic unipolar major depression and ischemic heart disease were randomly assigned to double-blind treatment with paroxetine or nortriptyline for 6 weeks. Paroxetine was administered at a fixed-flexible dose of 20–30 mg/day. Nortriptyline dose was adjusted with the use of blood-level monitoring to reach a plasma concentration of 50–150 ng/ml. RESULTS: Twenty-seven of the 41 patients who started treatment with paroxetine and 29 of the 40 patients who started treatment with nortriptyline had an improvement of at least 50% in their Hamilton Depression Rating Scale scores. Significantly more patients taking nortriptyline discontinued treatment prematurely (35% versus 10%), and more patients taking nortriptyline had adverse events resulting in termination (25% versus 5%). CONCLUSIONS: Both treatments were efficacious. Sixty-three percent of all patients improved at least 50%, and of these, 90% met the criteria for remission. Paroxetine was better tolerated than nortriptyline and less likely to produce cardiovascular side effects.

This article has been cited by other articles:

				S. A. Thomas, D. W. Chapa, E. Friedmann, C. Durden, A. Ross, M. C. Y. Lee, and H.-J. Lee Depression in Patients With Heart Failure: Prevalence, Pathophysiological Mechanisms, and Treatment Crit. Care Nurse, April 1, 2008; 28(2): 40 - 55. [Full Text] [PDF]

				Depression, antidepressants and heart disease DTB, April 1, 2008; 46(4): 29 - 32. [Abstract] [Full Text] [PDF]

				S U Shah, Z Iqbal, A White, and S White Heart and mind: (2) psychotropic and cardiovascular therapeutics Postgrad. Med. J., January 1, 2005; 81(951): 33 - 40. [Abstract] [Full Text] [PDF]

				W. Jiang, M. Kuchibhatla, M. S. Cuffe, E. J. Christopher, J. D. Alexander, G. L. Clary, M. A. Blazing, L. H. Gaulden, R. M. Califf, R. R. Krishnan, et al. Prognostic Value of Anxiety and Depression in Patients With Chronic Heart Failure Circulation, November 30, 2004; 110(22): 3452 - 3456. [Abstract] [Full Text] [PDF]

				S. P. Roose, H. A. Sackeim, K. R. R. Krishnan, B. G. Pollock, G. Alexopoulos, H. Lavretsky, I. R. Katz, H. Hakkarainen, and Old-Old Depression Study Group Antidepressant Pharmacotherapy in the Treatment of Depression in the Very Old: A Randomized, Placebo-Controlled Trial Am J Psychiatry, November 1, 2004; 161(11): 2050 - 2059. [Abstract] [Full Text] [PDF]

				M. J. Zellweger, R. H. Osterwalder, W. Langewitz, and M. E. Pfisterer Coronary artery disease and depression Eur. Heart J., January 1, 2004; 25(1): 3 - 9. [Abstract] [Full Text] [PDF]

				M. I. Lapid and T. A. Rummans Evaluation and Management of Geriatric Depression in Primary Care Mayo Clin. Proc., November 1, 2003; 78(11): 1423 - 1429. [Abstract] [PDF]

				L. S. Schneider, J. C. Nelson, C. M. Clary, P. Newhouse, K. R. R. Krishnan, T. Shiovitz, K. Weihs, and the Sertraline Elderly Depression Study Group An 8-Week Multicenter, Parallel-Group, Double-Blind, Placebo-Controlled Study of Sertraline in Elderly Outpatients With Major Depression Am J Psychiatry, July 1, 2003; 160(7): 1277 - 1285. [Abstract] [Full Text] [PDF]

				D. S. Charney, C. F. Reynolds III, L. Lewis, B. D. Lebowitz, T. Sunderland, G. S. Alexopoulos, D. G. Blazer, I. R. Katz, B. S. Meyers, P. A. Arean, et al. Depression and Bipolar Support Alliance Consensus Statement on the Unmet Needs in Diagnosis and Treatment of Mood Disorders in Late Life Arch Gen Psychiatry, July 1, 2003; 60(7): 664 - 672. [Abstract] [Full Text] [PDF]

				Writing Committee for the ENRICHD Investigators Effects of Treating Depression and Low Perceived Social Support on Clinical Events After Myocardial Infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial JAMA, June 18, 2003; 289(23): 3106 - 3116. [Abstract] [Full Text] [PDF]

				C. R. Weinert Epidemiology of Psychiatric Medication Use in Patients Recovering From Critical Illness at a Long-term Acute-Care Facility Chest, February 1, 2001; 119(2): 547 - 553. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us